tiprankstipranks
Addus Homecare (ADUS)
NASDAQ:ADUS
US Market
Want to see ADUS full AI Analyst Report?

Addus Homecare (ADUS) Blogger Opinions & Sentiment

364 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
ADUS Blogger sentiment is based on 5 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
40% SeekingAlpha
20% Investing
20% Zacks
20% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

ADUS SWOT Analysis: Strong Growth Potential Revealed in 10-Q Filing
GuruFocus
Can Volume Growth and RPT Recovery Support DaVita's Q2 Earnings
Zacks
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of ADUS?
Seeking Alpha’s Pod Investor has a Bullish Sentiment.
    What do Motley Fool contributors think of ADUS?
    Currently there's no blogger sentiment for ADUS.
    What Is ADUS’s Blogger Sentiment?
    ADUS’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for ADUS?
      The most recent blogger prediction for ADUS was made by GuruFocus News, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CADLCandel Therapeutics
          MLTXMoonLake Immunotherapeutics
          ZVRAZevra Therapeutics
          SMMTSummit Therapeutics
          TGTXTG Therapeutics